WAVE Life Sciences Ltd SELECT-HD Clinical Trial Update Transcript
Good morning, and welcome to the Wave Life Sciences SELECT-HD clinical trial update conference call. (Operator Instructions). As a reminder, this call is being recorded and webcast. I will now turn the call over to Kate Rausch, VP of Investor Relations and corporate Affairs at Wave Life Sciences. Please go ahead.
Thank you, operator. Good morning, and thank you for joining us today. This morning, we issued a news release providing an update on our SELECT-HD clinical trial. A slide presentation to accompany this webcast is available at the Investors section of our website, www.wavelifesciences.com. A replay of this call will also be available on the website following the call. Joining me in the room today with prepared remarks are Dr. Paul Bolno, Wave's President and Chief Executive Officer; and Dr. Mike Panzara, Chief Medical Officer, Head of Therapeutics Discovery and Development.
Following the prepared remarks, we'll be available
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |